Abstract: The invention relates to the use of acacia gum (or gum Arabic) possibly in combination with sulphur-containing amino acids, for improving the growth and survival of bifidobacteria which are part of the manufacture of fermented food products, in particular, of fermented milk products.
Type:
Grant
Filed:
October 1, 2007
Date of Patent:
February 3, 2015
Assignee:
Compagnie Gervais Danone
Inventors:
Luc Terragno, François Debru, Stéphane Herve, Philippe Teissier
Abstract: The flanged container for a dairy product or similar food composition is provided with a hollow body and a generally planar annular flange connected to the top of the body, the flange having outer straight side edges and an inner edge defining a circular upper opening of the container. The body has a planar bottom and a lower portion tapering from a generally cylindrical upper portion toward the bottom in a curved manner. The lower portion has a height h1 in some embodiments not less than 14 mm and the ratio h1/H is less than 2:5 where H is the height of the container. The side wall of the body has a thickness profile such that the average thickness of the lower portion is more than the average thickness of the upper portion. Several identical containers can be grouped in a pack with breakable junctions at the outer straight side edges.
Abstract: The packaging for a food product is provided with a container having an opening delimited by a frame, the frame having a radially inner side wall, and a lid. The lid can move between an open position and a closed position in which it closes off the opening. A measuring utensil with a bowl can be positioned in the plane of the frame. The inner side wall of the frame is provided with a retaining member which has a base extending from the frame towards the central axis of the container and that is extended by a tab extending upwards some distance from the inner side wall. The retaining member delimits, with the inner side wall, a slot-like housing capable with a small amount of clearance of accommodating a wall portion of the bowl.
Type:
Grant
Filed:
June 18, 2012
Date of Patent:
December 2, 2014
Assignee:
Compagnie Gervais Danone
Inventors:
Patrick VanDamme, Frédéric Bourdin, Francis Lovell
Abstract: The invention relates to reuterin-producing strains of Lactobacillus brevis. These strains are useful in particular for the treatment or the prevention of conditions resulting from Helicobacter pylori infection.
Abstract: The plastic bottle (1) is filled with liquid and provided with a neck (4) that defines a narrow opening (5) with an inner diameter typically inferior to 40 mm. A flexible sheet-like cover member (C), having a lower closing element (C1) and an upper label element (C2), is provided to seal the opening. A first portion (10) that defines a first surface of the label element is directly fastened to a central portion (6) of the closing element in contact with the upper face of the neck and reinforces this central portion. A second portion (L), which is entirely offset relative to the upper face of the neck, defines a second surface of the label element. The ratio between the second surface (S2) and the first surface (S1) is at least 1:2, and preferably at least 1:1. The second portion (L) extends above the shoulder 3 of the bottle.
Type:
Application
Filed:
December 17, 2012
Publication date:
November 6, 2014
Applicants:
COMPAGNIE GERVAIS DANONE, SA DES EAUX MINERALES D'EVIAN SAEME
Inventors:
Frederic Jouin, Christine Gehringer, Jennifer Ostertag
Abstract: Milk based compositions especially fermented and non-fermented milk products such as yogurt, beverages, and desserts, including a significant percentage of real milk are disclosed herein. The disclosed milk compositions particularly include wheat and rice flour and are substantially free of gelling agent(s) and modifies starch. A process for making such milk based compositions is also disclosed. The milk based compositions disclosed herein may contain other ingredients.
Abstract: The present invention relates to the use of the probiotic strain of Lactobacillus paracasei subsp. paracasei deposited at the CNCM under the reference I-3689, for inhibiting in vivo infection by Listeria monocytogenes.
Abstract: The present application relates to an inoculum that is particularly suitable for the direct inoculation of at least one stran of Bifidobacterium animalis ssp. lactis in a dairy substrate, for the conversion of said dairy substrate into a fermented dairy product. This inoculum comprises, in mixture or in collection form, the L-cysteine base and at least one strain of B. animalis lactis. Said cysteine and said at least one strain of B. animalis lactis are each contained in, or in the form of frozen and/or lyophilizate granules. Advantageously, said cysteine is incorporated within the same granules or the same lyophilizate as the cells of B. animalis lactis.
Abstract: The invention concerns a composition comprising a calcium salt and its preparation process. The calcium salt is a salt of Ca2+ ions and PO43? ions or HPO42?. The composition is appropriate for introduction in food products.
Abstract: The present invention relates to a new strain of Lactobacillus delbrueckii subsp. bulgaricus, suitable for use in the treatment or prevention of Helicobacter pylori infection.
Type:
Application
Filed:
August 9, 2011
Publication date:
July 24, 2014
Applicant:
COMPAGNIE GERVAIS DANONE
Inventors:
Peggy Garault, Gaelle Quere, Raphaelle Bourdet-Sicard, Francis Megraud
Abstract: The invention concerns a composition that can substitute yogurts. The composition comprises water, a rice concentrate, a cereal flour, a vegetal protein source, and a thickening agent.
Type:
Application
Filed:
July 4, 2012
Publication date:
June 12, 2014
Applicants:
DONONE GMBH, COMPAGNIE GERVAIS DANONE
Inventors:
Christoph Briegleb, Elini Chiotelli, Evelyn Krämer, Arnaud Lyothier
Abstract: The invention relates to a composition comprising a combination of an elder extract (Sambucus nigra) and a strain of L. paracasei, L. casei, L. bulgaricus or S. thermophilus, intended for stimulating immunity and/or promoting an anti-infectious and/or anti-inflammatory response.
Type:
Grant
Filed:
October 16, 2009
Date of Patent:
May 27, 2014
Assignees:
Pierre Fabre Medicament, Compagnie Gervais Danone
Abstract: The present invention relates to a method using Caenorhabditis elegans for screening of food grade bacteria which have a protective effect against oxidative stress.
Abstract: The invention concerns micro-organism strains, in particular of lactic acid bacteria, having a glycosylation modulating effect of intestinal cell surface. The invention also concerns a method for selecting micro-organism strains, in particular of lactic acid bacteria, which consists in measuring the average fluorescence intensity variation of HT29-MTX cells incubated in the presence of a lectin coupled with a fluorochrome after being in contact with the supernatant of the strain concerned. Said lactic acid bacteria strains can be used, optionally in the form of their active fraction, for preparing food compositions or medicines or food supplements, modulating glycosylation of glycoproteins of intestinal epithelial cells.
Type:
Grant
Filed:
November 16, 2005
Date of Patent:
May 20, 2014
Assignee:
Compagnie Gervais Danone
Inventors:
Jean-Michel Antoine, Miguel Freitas, Chantal Cayuela, Germain Trugnan
Abstract: The present invention relates to a method for decreasing borborygmi in a subject by administering a probiotic, preferably a bacteria of the Bifidobacterium genus, said method being on one aspect of the invention a non therapeutic method.
Type:
Grant
Filed:
May 26, 2009
Date of Patent:
May 6, 2014
Assignee:
Compagnie Gervais Danone
Inventors:
Denis Guyonnet, Stefan Jakob, Armelle Schlumberger